Viral bronchiolitis is the most common cause of admission to hospital for infants in high-
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …

Background To assess the published evidence to establish the efficacy and safety of high
flow oxygen cannula (HFNC) as respiratory support for children up to 24 months of age with …

High-flow nasal cannula (HFNC) is a relatively safe and effective noninvasive ventilation
method that was recently accepted as a treatment option for acute respiratory support before …

Objectives To evaluate the efficacy of high-flow nasal cannula (HFNC) oxygen therapy in
providing respiratory support of children with acute lower respiratory infection (ALRI) …

OBJECTIVES: We present a systematic review on the effectiveness of noninvasive
respiratory support techniques in bronchiolitis. DATA SOURCES: Systematic review with …

High-flow nasal cannula (HFNC) oxygen therapy has rapidly become a popular modality of
respiratory support in pediatric care. This is undoubtedly due to its ease of use and safety …

Bronchiolitis (BR), a lower respiratory tract infection mainly caused by respiratory syncytial
virus (RSV), can be very severe. Presently, adequate nutritional support and oxygen therapy …

Background and objective High-flow (HF) oxygen therapy is being used increasingly in
infants with bronchiolitis, despite lack of convincing evidence of its superiority over low flow …

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection
among infants and young children, resulting in annual epidemics worldwide. Since the …

Background High-flow nasal cannula (HFNC) and noninvasive ventilation (NIV) have been
used for the treatment of COPD and respiratory failure in clinical settings. We aimed to …